A Sensitive MSD-ECL Platform for In Vivo Pharmacokinetic Profiling of ADCs
Integrative Analysis of Proteomic, Transcriptomic, and FACS-based Surface Marker Data for ADC Target Discovery in Cancer Cell Lines
Reaction Signals Q4 2025 – ADCs Edition
